For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
Op-Eds
Do We Really Need a National Weather Service?
As Hurricane Irene bears down on the East Coast, news stations bombard our televisions with constant updates from the National Hurricane Center. While Americans ought…
Washington Times
Questionable Motives Behind Supplement Bill
Washington Times
Medical Magellans
Food and Drug Administration (FDA) rules are supposedly intended to ensure the safety and efficacy of new drugs and medical devices. It is FDA’s technology…
Reason
The High Cost of Low Fuel Bills
Blog
Weird Healthcare Regulation of the Day: No Coverage for Men With Breast Cancer
"Disease does not discriminate, but apparently Medicaid coverage does. A 26-year-old South Carolina tile-layer has found himself with breast cancer and out of luck for…
Fox Business
